Clinical Trial: This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649122) titled 'This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.' on June 11.

Brief Summary: This study evaluates the diagnostic performance and safety of 68Ga-NYM032 PET/CT imaging in patients with suspected recurrence of prostate cancer.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Prostate Cancer

Intervention: DIAGNOSTIC_TEST: 68-Ga-NYM032

IV injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Norroy Bioscience Co., LTD

Published by HT Digital Content Services with permission from Health Daily Digest....